# Seqster PDM

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/seqster-pdm

- Industry: Healthcare IT
- Headquarters: San Diego, US
- Website: www.seqster.com
- Total disclosed funding: $12M
- Latest round: Series A (Apr 21, 2021)
- Investors on record: 2

## About

Seqster PDM, Inc. offers a healthcare data interoperability platform that enables users to access and integrate personal health data from multiple sources, enhancing patient engagement and outcomes across the healthcare spectrum.Founded in 2016, Seqster PDM, Inc. is headquartered in San Diego, US. The company specializes in healthcare data interoperability, aggregating electronic health records, genomic data, and information from wearable devices. Its latest funding round, Series A, raised USD 12.000 mn in April 2021, led by OMNI Healthcare with participation from Takeda Ventures. The founders, Dana Hosseini and Xiang Li, have backgrounds in health technology and innovation. Seqster has completed a total of 1 deal to date.Seqster offers a comprehensive healthcare data interoperability platform designed to provide real-time access to personal health data. Their core product aggregates patient data from various sources, including electronic health records (EHR), genomic information, and wearable health devices, enabling users to create a matched, longitudinal health data profile. This integration facilitates enriched studies with more comprehensive personal health data, allowing healthcare organizations to populate cohorts with detailed clinical data efficiently. The platform is utilized by healthcare providers, researchers, and organizations aiming to improve patient engagement and outcomes. Specific end users include patients, blood donors through partnerships such as that with the San Diego Blood Bank, and healthcare organizations across the United States, which leverage Seqster's technology to foster improved health management and monitoring.Seqster generates revenue through a subscription-based model, where healthcare organizations and partners pay to access its data interoperability services. The company also engages in strategic partnerships with entities like PatientsLikeMe and icometrix, enhancing their service offerings and expanding their market reach. These partnerships contribute to the overall revenue structure by enabling collaborative projects and shared technological developments. Seqster's flagship offerings, such as its 1-Click Records™ solution, enable quick data integration for clinical trials and other studies, providing additional avenues for revenue generation through specialized services tailored to the needs of their clients. While specific pricing details are proprietary to the company, the subscription models typically vary based on the scale of data integration and the specific services utilized by the clients.In April 2021, Seqster raised USD 12.000 mn in Series A funding led by OMNI Healthcare, aimed at expanding its offerings in healthcare where its software has numerous applications. The company plans to utilize the funding to accelerate the development of new products and expand its technology capabilities. Seqster is targeting growth into new markets, particularly focusing on enhancing its presence within the healthcare industry across various regions in the US. Upcoming product launches include improvements to their data integration solutions, although specific release dates have not been disclosed.

## Funding rounds

- Series A, Apr 21, 2021, $12M — Takeda Ventures, OMNI Healthcare

## Investors

- Takeda Ventures (https://capitalatlas.ai/funds/takeda-ventures) — Series A
- OMNI Healthcare — Series A